Concepedia

Athanasia Papadimitriou

AP

4

Publications

156

Citations

4

H-Index

2018

Active since

Affiliations

Takeda (Switzerland)(Current)

Takeda (United States)

Athanasia Papadimitriou is an author at Takeda (Switzerland) specializing in cancer research, radiation oncology, and lung cancer.

Top concepts

Publications per year

2018–2023

4

Publications

4

Alpelisib for treatment of patients with PIK3CA-related overgrowth spectrum (PROS)

Guillaume Canaud, Juan Carlos López‐Gutiérrez, Alan D. Irvine et al. · Genetics in Medicine · 2023 · 70 citations · Full text

, , +5

A phase 1 study of safety and immunogenicity following intradermal administration of a tetravalent dengue vaccine candidate

Lisa A. Jackson, Richard Rupp, Athanasia Papadimitriou et al. · Vaccine · 2018 · 42 citations · Full text

Immunogenicity and safety of lyophilized and liquid dengue tetravalent vaccine candidate formulations in healthy adults: a randomized, phase 2 clinical trial

M. Turner, Athanasia Papadimitriou, Peter Winkle et al. · Human Vaccines & Immunotherapeutics · 2020 · 29 citations · Full text

Long-term Safety and Immunogenicity of a Tetravalent Dengue Vaccine Candidate in Children and Adults: A Randomized, Placebo-Controlled, Phase 2 Study

Chukiat Sirivichayakul, Elizabeth A Barranco-Santana, Inés Esquilín Rivera et al. · The Journal of Infectious Diseases · 2020 · 15 citations · Full text

Rows per page

1–4 of 4